Cargando…

Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study

We evaluated a population-based cohort of metastatic well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors (G3 NETs) to describe their characteristics, prognosis, and treatment outcomes. METHODS: The British Columbia provincial database was queried for G3 NETs diagnosed 2004 to 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutin, Mélina, Mathews, Angela, Badesha, Jasleen, Paul, Ashley, Safro, Maria, Gill, Sharlene, Stuart, Heather C., Schaeffer, David, Farnell, David, Loree, Jonathan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722384/ https://www.ncbi.nlm.nih.gov/pubmed/36395400 http://dx.doi.org/10.1097/MPA.0000000000002100

Ejemplares similares

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
por: Badesha, Jasleen K., et al.
Publicado: (2023)

Controversies and management of deficient mismatch repair gastrointestinal cancers in the neoadjuvant setting
por: Boutin, Mélina, et al.
Publicado: (2023)

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020)

Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors
por: Hashmi, Atif A, et al.
Publicado: (2021)

Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report
por: Ito, Misato, et al.
Publicado: (2020)

Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
por: Solar Vasconcelos, Joao Paulo, et al.
Publicado: (2022)

Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
por: Pellat, Anna, et al.
Publicado: (2020)

Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
por: Pellat, Anna, et al.
Publicado: (2021)

Neuroendocrine Tumor, Well Differentiated, of the Breast: A Relatively High-Grade Case in the Histological Subtype
por: Tajima, Shogo, et al.
Publicado: (2013)

A Well-Differentiated Grade-3 Neuroendocrine Tumor in the Ascending Colon: A Case Report
por: AlSaffar, Ali, et al.
Publicado: (2022)

The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021)

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience
por: Sahu, Arvind, et al.
Publicado: (2019)

Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review
por: Toor, Deepak, et al.
Publicado: (2022)

Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting
por: Loree, Jonathan, et al.
Publicado: (2021)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
por: Prasad, Vishnu, et al.
Publicado: (2023)

Clinical characteristic and prognostic factors in high‐grade endometrial neuroendocrine carcinoma
por: Zhang, Zhifang, et al.
Publicado: (2022)

Two well-differentiated pancreatic neuroendocrine tumor mouse models
por: Wong, Chung, et al.
Publicado: (2019)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
por: Xu, Jun-Xi, et al.
Publicado: (2021)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Dietary Factors as Triggers of Low-Grade Chronic Intestinal Inflammation in Poultry
por: Cardoso Dal Pont, Gabriela, et al.
Publicado: (2020)

Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix
por: Zhu, Ran, et al.
Publicado: (2019)

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
por: Hofland, Johannes, et al.
Publicado: (2020)

Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors
por: Kim, Min Jeong, et al.
Publicado: (2018)

Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case
por: Manneh, Ray, et al.
Publicado: (2016)

Synaptophysin-Ki67 Double Stain: A Novel Technique That Improves Interobserver Agreement in the Grading of Well-Differentiated Gastrointestinal Neuroendocrine Tumors
por: Matsukuma, Karen, et al.
Publicado: (2017)

Low Grade Neuroendocrine Tumors of the Lung
por: Melosky, Barbara
Publicado: (2017)

A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada
por: Cheung, Winson Y., et al.
Publicado: (2022)

Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns?
por: Kalyta, Anastasia, et al.
Publicado: (2021)

Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021)

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
por: Zhao, Shuang G., et al.
Publicado: (2022)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
por: Loree, Jonathan M., et al.
Publicado: (2016)

Real-world treatment attrition rates in advanced esophagogastric cancer
por: Tsang, Erica S, et al.
Publicado: (2020)

Comparing Deep Learning and Immunohistochemistry in Determining the Site of Origin for Well-Differentiated Neuroendocrine Tumors
por: Redemann, Jordan, et al.
Publicado: (2020)

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
por: Abdelmalak, Rebecca, et al.
Publicado: (2021)

Neuroendocrine Differentiation In Prostate Adenocarcinoma Biopsies And Its Correlation To Histological Grading
por: Marcu, Mădălina, et al.
Publicado: (2010)

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
por: Leoncini, Emanuele, et al.
Publicado: (2017)

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors
por: Marchese, Ugo, et al.
Publicado: (2022)

Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline
por: Yu, Irene S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ts4srhp98pa9s201tv1ioakfbs